Diethylstilbestrol inhibits phospholipase D activity and degranulation by stimulated human neutrophils.
In the present study the effects of diethylstilbestrol on phospholipase D activity and degranulation by human neutrophils were examined. Diethylstilbestrol is a synthetic estrogen and has structural similarity to resveratrol. Resveratrol is a natural polyphenolic antioxidant and has been shown to inhibit the activity of phospholipase D in stimulated neutrophils. Phospholipase D catalyzes the hydrolysis of phosphatidylcholine to yield phosphatidic acid and choline. It also catalyzes the transfer of the phosphatidyl group to ethanol forming phosphatidylethanol at the expense of phosphatidic acid. Phospholipase D activation is associated with degranulation by neutrophils stimulated with chemotactic peptide, formyl-methionyl-leucyl-phenylalanine. The results show that diethylstilbestrol at 100 microM induced a complete inhibition of phosphatidic acid formation in neutrophils, the latter activated by chemotactic peptide. In the presence of ethanol, diethylstilbestrol dose dependently reduced phosphatidylethanol formation induced by chemotactic peptide or by phorbol 12-myristate 13-acetate, indicative of diethylstilbestyrol inhibition of phospholipase D activity. The results also demonstrate that diethylstilbestrol inhibited degranulation by chemotactic peptide-stimulated neutrophils. In comparison to resveratrol, diethylstilbestrol exhibits a stronger inhibition on PA formation, phospholipase D activity and degranulation. These findings suggest that diethylstilbestrol-like resveratrol, may have anti-inflammatory effect in vitro.
Tou
Jen-Sie
JS
Department of Biochemistry, Tulane University Health Sciences Center School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, United States. Pandjtou@aol.com
Urbizo
Carolina
C
D000893:Anti-Inflammatory Agents; D015550:Cell Degranulation / Q000187:drug effects*; D002478:Cells, Cultured; D004054:Diethylstilbestrol / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D018375:Neutrophil Activation; D009504:Neutrophils; D010712:Phosphatidic Acids / Q000037:antagonists & inhibitors; D010739:Phospholipase D / Q000187:drug effects*
D000893:Anti-Inflammatory Agents; D010712:Phosphatidic Acids; D009240:N-Formylmethionine Leucyl-Phenylalanine; D004054:Diethylstilbestrol; D010739:Phospholipase D